Brief: Aurinia Announces Board Restructuring
12/09/2024 22:52
Aurinia Pharmaceuticals Inc AUPH.O :
* AURINIA ANNOUNCES BOARD RESTRUCTURING
* AURINIA PHARMACEUTICALS - PETER GREENLEAF, PRESIDENT &
CEO,
REMAINS DIRECTOR
* AURINIA PHARMACEUTICALS INC - RESTRUCTURED BOARD CONSISTS
OF
SEVEN MEMBERS
Source text for Eikon: ID:nBw4ZVbLPa
Further company coverage: AUPH.O
Recent news on Aurinia Pharmaceuticals
See all newsBrief: Aurinia Settles Patent Litigation With Teva
Canada's Aurinia Q2 revenue rises on LUPKYNIS sales
Brief: Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview
Brief: Lupkynis Associated With A Statistically Significant 53% Reduction In Risk Of Renal-Related Event Or Death